The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
“Stormy waters ahead”: global emergence of carbapenemases
Open accessAbstract
Carbapenems, once considered the last line of defense against of serious infections with Enterobacteriaceae, are threatened with extinction. The increasing isolation of carbapenem-resistant Gram-negative pathogens is forcing practitioners to rely on uncertain alternatives. As little as 5 years ago, reports of carbapenem resistance in Enterobacteriaceae, common causes of both community and healthcare-associated infections, were sporadic and primarily limited to case reports, tertiary care centers, intensive care units, and outbreak settings. Carbapenem resistance mediated by β-lactamases, or carbapenemases, has become widespread and with the paucity of reliable antimicrobials available or in development, international focus has shifted to early detection and infection control. However, as reports of Klebsiella pneumoniae carbapenemases, New Delhi metallo-β-lactamase-1, and more recently OXA-48 (oxacillinase-48) become more common and with the conveniences of travel, the assumption that infections with highly resistant Gram-negative pathogens are limited to the infirmed and the heavily antibiotic and healthcare exposed are quickly being dispelled. Herein, we provide a status report describing the increasing challenges clinicians are facing and forecast the "stormy waters" ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
Self-citationKumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Walsh, T. R., Weeks, J., Livermore, D. M., & Toleman, M. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70059-7 · Cited by 1,250
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Self-citationCarbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Gupta, N., Limbago, B. M., Patel, J. B., & Kallen, A. J. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir202 · Cited by 1,033
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Woodford, N., Turton, J. F., & Livermore, D. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00268.x · Cited by 885
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
Cantón, R., Akóva, M., Carmeli, Y., Giske, C. G., Glupczynski, Y., Gniadkowski, M., Livermore, D. M., Miriagou, V., Naas, T., Rossolini, G. M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03821.x · Cited by 883
Lauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
The emerging NDM carbapenemases
Nordmann, P., Poirel, L., Walsh, T. R., & Livermore, D. M. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.09.005 · Cited by 663
Diversity, Epidemiology, and Genetics of Class D β-Lactamases
Poirel, L., Naas, T., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01512-08 · Cited by 632
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., Polsky, B., Adams-Haduch, J. M., & Doi, Y. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06268-11 · Cited by 559
Heteroresistance to Colistin in Multidrug-Resistant Acinetobacter baumannii
Li, J., Rayner, C. R., Nation, R. L., Owen, R. J., Spelman, D., Tan, K. E., & Liolios, L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00103-06 · Cited by 548
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Schwaber, M. J., Klarfeld-Lidji, S., Navon-Venezia, S., Schwartz, D., Leavitt, A., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-07 · Cited by 483
Hirsch, E. B., & Tam, V. H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq108 · Cited by 477
Schwaber, M. J., Lev, B., Israeli, A., Solter, E., Smollan, G., Rubinovitch, B., Shalit, I., Carmeli, Y., & the Israel Carbapenem-Resistant Enterobacteriaceae Working Group (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir025 · Cited by 453
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Worldwide Dissemination of the blaOXA-23Carbapenemase Gene of Acinetobacter baumannii 1
Mugnier, P. D., Poirel, L., Naas, T., & Nordmann, P. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1601.090852 · Cited by 431
Lledo, W., Hernández, M., Lopez, E., Molinari, O. L., Soto, R. Q., Hernández, E., Vispo, N. S., Flores, M., Vázquez, G. J., Robledo, I. E., et al. (2009) · PubMed · Cited by 430
Identification and screening of carbapenemase-producing Enterobacteriaceae
Nordmann, P., Gniadkowski, M., Giske, C. G., Poirel, L., Woodford, N., & Miriagou, V. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03815.x · Cited by 408
Genetic Features of bla NDM-1 -Positive Enterobacteriaceae
Poirel, L., Dortet, L., Bernabeu, S., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00585-11 · Cited by 404
Scott, P., Deye, G., Srinivasan, A., Murray, C., Moran, K., Hulten, E., Fishbain, J., Craft, D., Riddell, S., Lindler, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/518170 · Cited by 393
ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China
Qi, Y., Wei, Z., Ji, S., Du, X., Shen, P., & Yu, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq431 · Cited by 345
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
Gales, A. C., Castanheira, M., Jones, R. N., & Sader, H. S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.04.007 · Cited by 318
Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2Gene1
Cuzon, G., Naas, T., Truong, H., Villegas, M.-V., Wisell, K. T., Carmeli, Y., Gales, A. C., Navon-Venezia, S., Quinn, J. P., & Nordmann, P. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1609.091389 · Cited by 307
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose
Rodvold, K. A., Gotfried, M. H., Cwik, M., Korth-Bradley, J. M., Dukart, G., & Ellis-Grosse, E. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl403 · Cited by 304
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae
van der Bij, A. K., & Pitout, J. D. D. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks214 · Cited by 292
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Spread of OXA-48-Encoding Plasmid in Turkey and Beyond
Carrër, A., Poirel, L., Yilmaz, M., Akan, O. A., Feriha, C., Cuzon, G., Matar, G., Honderlick, P., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01312-09 · Cited by 273
Walther-Rasmussen, J., & Høiby, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm226 · Cited by 271
Ito, H., Arakawa, Y., Ohsuka, S., Wacharotayankun, R., Kato, N., & Ohta, M. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.824 · Cited by 266
Efficacy and safety of tigecycline: a systematic review and meta-analysis
Yahav, D., Lador, A., Paul, M., & Leibovici, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr242 · Cited by 266
Castanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis
Tasina, E., Haidich, A.-B., Kokkali, S., & Arvanitidou, M. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70177-3 · Cited by 260
Carbapenemase-Producing Enterobacteriaceae
Paterson, D., & Doi, Y. (2015) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0035-1544208 · Cited by 257
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Synthesis and Spectrum of the Neoglycoside ACHN-490
Aggen, J. B., Armstrong, E. S., Goldblum, A. A., Dozzo, P., Linsell, M. S., Gliedt, M. J., Hildebrandt, D. J., Feeney, L. A., Kubo, A., Matias, R. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00572-10 · Cited by 243
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt
Kaase, M., Nordmann, P., Wichelhaus, T. A., Gatermann, S. G., Bonnin, R. A., & Poirel, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr135 · Cited by 231
Karageorgopoulos, D. E., Wang, R., Yu, X.-H., & Falagas, M. E. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr466 · Cited by 228
Tigecycline: A New Glycylcycline for Treatment of Serious Infections
Noskin, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/431672 · Cited by 226
Brown, S., Young, H. K., & Amyes, S. G. B. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01016.x · Cited by 225
Rasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Tn 125 -Related Acquisition of bla NDM -Like Genes in Acinetobacter baumannii
Poirel, L., Bonnin, R. A., Boulanger, A., Schrenzel, J., Kaase, M., & Nordmann, P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05620-11 · Cited by 216
Endimiani, A., Hujer, A. M., Perez, F., Bethel, C. R., Hujer, K. M., Kroeger, J., Oethinger, M., Paterson, D. L., Adams, M. D., Jacobs, M. R., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn547 · Cited by 216
Self-citationAnthony, K. B., Fishman, N. O., Linkin, D. R., Gasink, L. B., Edelstein, P. H., & Lautenbach, E. (2008) · Clinical Infectious Diseases · doi:10.1086/526775 · Cited by 210
Outbreak of OXA-48-Positive Carbapenem-Resistant Klebsiella pneumoniae Isolates in France
Cuzon, G., Ouanich, J., Gondret, R., Naas, T., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01452-10 · Cited by 209
Pfeifer, Y., Wilharm, G., Zander, E., Wichelhaus, T. A., Göttig, S., Hunfeld, K.-P., Seifert, H., Witte, W., & Higgins, P. G. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr256 · Cited by 207
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin
Zhanel, G. G., Lawson, C. D., Zelenitsky, S., Findlay, B., Schweizer, F., Adam, H., Walkty, A., Rubinstein, E., Gin, A. S., Hoban, D. J., et al. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.25 · Cited by 201
Perez, F., Endimiani, A., Ray, A. J., Decker, B. K., Wallace, C. J., Hujer, K. M., Ecker, D. J., Adams, M. D., Toltzis, P., Dul, M. J., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq191 · Cited by 194
Self-citationCai, J. C., Zhou, H. W., Zhang, R., & Chen, G.-X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01539-07 · Cited by 190
Cai, Y., Wang, R., Liang, B., Bai, N., & Liu, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01402-10 · Cited by 189
Miriagou, V., Tzouvelekis, L. S., Rossiter, S., Tzelepi, E., Angulo, F. J., & Whichard, J. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1297-1300.2003 · Cited by 188
The emergence of clinical resistance to tigecycline
Sun, Y., Cai, Y., Liu, X., Bai, N., Liang, B., & Wang, R. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.005 · Cited by 185
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Poudyal, A., Howden, B. P., Bell, J. M., Gao, W., Owen, R. J., Turnidge, J. D., Nation, R. L., & Li, J. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn425 · Cited by 185
Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M., & Nordmann, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1262 · Cited by 184
Mathers, A. J., Cox, H. L., Kitchel, B., Bonatti, H., Brassinga, A. K. C., Carroll, J., Scheld, W. M., Hazen, K. C., & Sifri, C. D. (2011) · mBio · doi:10.1128/mbio.00204-11 · Cited by 183
Country-to-Country Transfer of Patients and the Risk of Multi-Resistant Bacterial Infection
Rogers, B. A., Aminzadeh, Z., Hayashi, Y., & Paterson, D. L. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir273 · Cited by 183
The Challenges of Antimicrobial Resistance in Brazil
Rossi, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir120 · Cited by 183
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
Mushtaq, S., Irfan, S., Sarma, J. B., Doumith, M., Pike, R., Pitout, J., Livermore, D. M., & Woodford, N. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr226 · Cited by 182
Docquier, J.-D., Calderone, V., De Luca, F., Benvenuti, M., Giuliani, F., Bellucci, L., Tafi, A., Nordmann, P., Botta, M., Rossolini, G. M., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.04.010 · Cited by 176
Samuelsen, O., Naseer, U., Tofteland, S., Skutlaberg, D. H., Onken, A., Hjetland, R., Sundsfjord, A., & Giske, C. G. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp018 · Cited by 171
Deshpande, L. M., Jones, R. N., Fritsche, T. R., & Sader, H. S. (2006) · Microbial Drug Resistance · doi:10.1089/mdr.2006.12.223 · Cited by 169
Characterization of OXA-204, a Carbapenem-Hydrolyzing Class D β-Lactamase from Klebsiella pneumoniae
Potron, A., Nordmann, P., & Poirel, L. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01034-12 · Cited by 169
Gülmez, D., Woodford, N., Palepou, M.-F. I., Mushtaq, S., Metan, G., Yakupogullari, Y., Kocagoz, S., Uzun, O., Hascelik, G., & Livermore, D. M. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.017 · Cited by 168
Therapeutic Options for Infections with Enterobacteriaceae Producing Carbapenem-Hydrolyzing Enzymes
Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011) · Future Microbiology · doi:10.2217/fmb.11.49 · Cited by 167
Lascols, C., Hackel, M., Marshall, S. H., Hujer, A. M., Bouchillon, S., Badal, R., Hoban, D., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr240 · Cited by 167
Self-citationYang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., & Jones, R. N. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn434 · Cited by 163
Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
Aubron, C., Poirel, L., Ash, R. J., & Nordmann, P. (2005) · Emerging infectious diseases · doi:10.3201/eid1102.030684 · Cited by 162
Poirel, L., Bonnin, R. A., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-11 · Cited by 162
Nordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Poirel, L., Castanheira, M., Carrër, A., Rodriguez, C. P., Jones, R. N., Smayevsky, J., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00022-11 · Cited by 155
Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
Meletis, G., Tzampaz, E., Sianou, E., Tzavaras, I., & Sofianou, D. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr007 · Cited by 154
Yau, W., Owen, R. J., Poudyal, A., Bell, J. M., Turnidge, J. D., Yu, H. H., Nation, R. L., & Li, J. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.11.002 · Cited by 152
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom
Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., MacDonald, A., Brudney, D., Sompolinsky, D., Navon‐Venezia, S., & Livermore, D. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn396 · Cited by 149
Hirsch, E. B., Ledesma, K. R., Chang, K., Schwartz, M. S., Motyl, M. R., & Tam, V. H. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05927-11 · Cited by 145
New treatment options against gram-negative organisms
Bassetti, M., Ginocchio, F., & Mikulska, M. (2011) · Critical Care · doi:10.1186/cc9997 · Cited by 139
Endimiani, A., Choudhary, Y., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00641-09 · Cited by 133
Self-citationSatlin, M. J., Kubin, C. J., Blumenthal, J. S., Cohen, A. B., Furuya, E. Y., Wilson, S. J., Jenkins, S. G., & Calfee, D. P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00387-11 · Cited by 132
Peirano, G., Schreckenberger, P. C., & Pitout, J. D. D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-10 · Cited by 131
Status report on carbapenemases: challenges and prospects
Patel, G., & Bonomo, R. A. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.28 · Cited by 131
Self-citationShahid, M., Sobia, F., Singh, A., Malik, A., Khan, H. M., Jonas, D., & Hawkey, P. M. (2009) · Critical Reviews in Microbiology · doi:10.1080/10408410902733979 · Cited by 131
In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters
Mushtaq, S., Warner, M., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq306 · Cited by 129
Marchaim, D., Chopra, T., Bhargava, A., Bogan, C., Dhar, S., Hayakawa, K., Pogue, J. M., Bheemreddy, S., Blunden, C. E., Shango, M. M., et al. (2012) · Infection Control and Hospital Epidemiology · doi:10.1086/666642 · Cited by 128
Self-citationMolecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
Adams‐Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G., Marschall, J., Urban, C. M., Spellberg, B. J., Rhee, D., Halstead, D. C., Pasculle, A. W., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-11 · Cited by 127
Crandon, J. L., Schuck, V., Banevicius, M. A., Beaudoin, M., Nichols, W. W., Tanudra, M. A., & Nicolau, D. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00851-12 · Cited by 118
Wolter, D. J., Kurpiel, P. M., Woodford, N., Palepou, M.-F. I., Goering, R. V., & Hanson, N. D. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00734-08 · Cited by 117
Lee, J., Patel, G., Huprikar, S. S., Calfee, D. P., & Jenkins, S. G. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02466-08 · Cited by 110
Self-citationGregory, C. J., Llata, E., Stine, N. W., Gould, C., Santiago, L. M., Vázquez, G. J., Robledo, I. E., Srinivasan, A., Goering, R. V., & Tomashek, K. M. (2010) · Infection Control and Hospital Epidemiology · doi:10.1086/651670 · Cited by 104
Levasseur, P., Girard, A.-M., Claudon, M., Goossens, H., Black, M. T., Coleman, K., & Miossec, C. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06064-11 · Cited by 102
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Epidemiology and Impact of Imipenem Resistance in Acinetobacter baumannii
Lautenbach, E., Synnestvedt, M. B., Weiner, M. G., Bilker, W. B., Vo, L., Schein, J. R., & Kim, M. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/648450 · Cited by 99
Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel
Ben-David, D., Masarwa, S., Navon‐Venezia, S., Mishali, H., Fridental, I., Rubinovitch, B., Smollan, G., Carmeli, Y., Schwaber, M. J., & Israel PACF CRKP (Post-Acute-Care Facility Carbapenem-Resistant Klebsiella pneumoniae) Working Group (2011) · Infection Control and Hospital Epidemiology · doi:10.1086/661279 · Cited by 98
Poirel, L., Rodríguez-Martínez, J. M., al Naiemi, N., Debets-Ossenkopp, Y. J., & Nordmann, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01456-09 · Cited by 90
Kassis, N., Decré, D., Gautier, V., Burghoffer, B., Saliba, F., Mathieu, D., Samuel, D., Castaing, D., Petit, J., Dussaix, É., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki389 · Cited by 89
Mushtaq, S., Warner, M., Williams, G. B., Critchley, I. A., & Livermore, D. M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq161 · Cited by 86
Viau, R. A., Hujer, A. M., Marshall, S. H., Pérez, F., Hujer, K. M., Briceno, D. F., Dul, M. J., Jacobs, M. R., Grossberg, R., Toltzis, P., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis036 · Cited by 79
Self-citationNDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates
Ghazawi, A., Sonnevend, Á., Bonnin, R. A., Poirel, L., Nordmann, P., Hashmey, R., Rizvi, T. A., Hamadeh, M. B., & Pál, T. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03726.x · Cited by 75
Fritsche, T. R., Strabala, P., Sader, H. S., Dowzicky, M. J., & Jones, R. N. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.010 · Cited by 75
Bilavsky, E., Schwaber, M. J., & Carmeli, Y. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833b3571 · Cited by 74
Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism
Adler, A., Shklyar, M., Schwaber, M. J., Navon‐Venezia, S., Dhaher, Y., Edgar, R., Solter, E., Benenson, S., Masarwa, S., & Carmeli, Y. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr382 · Cited by 71
First Report of the Metallo-β-Lactamase SPM-1 in Europe
Salabi, A. A. E., Toleman, M. A., Weeks, J. L., Bruderer, T., Frei, R., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00719-09 · Cited by 69
Walkty, A. J., DeCorby, M. R., Lagacé-Wiens, P. R. S., Karlowsky, J. A., Hoban, D. J., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01696-10 · Cited by 65
Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France
Poirel, L., Ros, A., Carrër, A., Fortineau, N., Carricajo, A., Berthelot, P., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr023 · Cited by 65
Russo, T. A., Page, M. G. P., Beanan, J. M., Olson, R., Hujer, A. M., Hujer, K. M., Jacobs, M. R., Bajaksouzian, S., Endimiani, A., & Bonomo, R. A. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr013 · Cited by 63
Self-citationIn vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae
Berçot, B., Poirel, L., Dortet, L., & Nordmann, P. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr296 · Cited by 62
Castanheira, M., Mendes, R. E., Walsh, T. R., Gales, A. C., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2344-2345.2004 · Cited by 56
NmcA Carbapenem-hydrolyzing Enzyme inEnterobacter cloacaein North America1
Pottumarthy, S., Moland, E. S., Juretschko, S., Swanzy, S. R., Thomson, K. S., & Fritsche, T. R. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030096 · Cited by 55
Higgins, P. G., Janßen, K., Fresen, M. M., et al. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01759-12 · Cited by 48
2-Substituted 4,5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases
Chen, P., Banks, L. D., Mikulski, R. L., Deng, L., Sundriyal, S., Palzkill, T. G., & Song, Y. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.012 · Cited by 39
Livermore, D. M., Mushtaq, S., & Warner, M. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq310 · Cited by 35
Vaara, M., Sader, H. S., Rhomberg, P. R., Jones, R., & Vaara, T. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks438 · Cited by 31
Pérez, F., Hujer, A. M., Hulten, E. A., Fishbain, J. T., Hujer, K. M., Aron, D. C., Thweatt, K. S., Donskey, C. J., & Bonomo, R. A. (2009) · American Journal of Infection Control · doi:10.1016/j.ajic.2009.05.007 · Cited by 25
Self-citationNew Treatment Options against Gram-negative Organisms
Bassetti, M., Ginocchio, F., & Mikulska, M. (2011) · Annual update in intensive care and emergency medicine · doi:10.1007/978-3-642-18081-1_46 · Cited by 24
Geffen, Y., Adler, A., Paikin, S., Khabra, E., Gorenshtein, S., Aronov, R., & Carmeli, Y. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks443 · Cited by 23
Cited by
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Carbapenem Resistance: A Review
Codjoe, F., & Donkor, E. (2017) · Medical Sciences · doi:10.3390/medsci6010001 · Cited by 746
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
King, A. M., Reid-Yu, S. A., Wang, W., King, D. T., De Pascale, G., Strynadka, N. C., Walsh, T. R., Coombes, B. K., & Wright, G. D. (2014) · Nature · doi:10.1038/nature13445 · Cited by 554
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
Huttner, A., Harbarth, S., Carlet, J., Cosgrove, S., Goossens, H., Holmes, A., Jarlier, V., Voss, A., Pittet, D., & participants, F. T. W. H.-A. I. F. (2013) · Antimicrobial Resistance and Infection Control · doi:10.1186/2047-2994-2-31 · Cited by 447
Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Durand-Réville, T. F., Lahiri, S., Thresher, J., Livchak, S., Gao, N., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485979 · Cited by 372
Metadata
- Authors
- Patel, G., & Bonomo, R. A.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 48-48
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2084720817
- Cited by
- 423
- References
- 131
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.